DOSEOLOGY SCIENCES INCDD

DOSEOLOGY SCIENCES INC

0,300CADR
−0,020−6,25%
Alla chiusura del 21 mar, 21:07 GMT
CAD
Nessun attività
Visualizza sui grafici

Fondamentali MOOD

DOSEOLOGY SCIENCES INC bilanci, compresi i ricavi, spese e i profitti

Il fatturato totale di MOOD per l'ultimo trimestre è di 4.61 k CAD, in calo del 68.41% rispetto al trimestre precedente. L'utile netto nel Q2 25 è di -58.41 k CAD.

Q1 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪‪−1,20 M‬‬
‪‪−800,00 K‬‬
‪‪−400,00 K‬‬
‪0,00‬
‪‪400,00 K‬‬
Fatturato totale
Utile lordo
Utile operativo
Utile lordo
Utile netto
Valuta: CAD
Q1 '21
Set 2020
Q1 '22
Set 2021
Q2 '22
Dic 2021
Q3 '22
Mar 2022
Q4 '22
Giu 2022
Q1 '23
Set 2022
Q2 '23
Dic 2022
Q3 '23
Mar 2023
Q4 '23
Giu 2023
Q1 '24
Set 2023
Q2 '24
Dic 2023
Q3 '24
Mar 2024
Q4 '24
Giu 2024
Q1 '25
Set 2024
Q2 '25
Dic 2024
TTM
Fatturato totaleCrescita YoY
‪‪9,81 K‬‬
+311,06%
‪‪11,06 K‬‬
−19,05%
‪‪46,10 K‬‬
+792,91%
‪‪13,27 K‬‬
−22,18%
‪‪33,85 K‬‬
+245,14%
‪‪5,30 K‬‬
−52,11%
‪‪14,58 K‬‬
−68,38%
‪‪4,61 K‬‬
−65,31%
‪‪58,33 K‬‬
‪‪−123,55 K‬‬
‪‪−51,42 K‬‬
‪‪−67,16 K‬‬
‪‪−20,48 K‬‬
‪‪−60,18 K‬‬
‪‪13,20 K‬‬
‪‪−45,43 K‬‬
‪‪−29,19 K‬‬
‪‪−121,59 K‬‬
Utile lordoCrescita YoY
‪‪−113,74 K‬‬
+51,80%
‪‪−40,36 K‬‬
+87,76%
‪‪−21,05 K‬‬
+90,04%
‪‪−7,20 K‬‬
+94,32%
‪‪−26,33 K‬‬
+76,85%
‪‪18,50 K‬‬
‪‪−30,85 K‬‬
−46,52%
‪‪−24,59 K‬‬
−241,47%
‪‪−63,27 K‬‬
‪‪−13,52 K‬‬
‪‪−145,04 K‬‬
‪‪−63,37 K‬‬
‪‪−131,67 K‬‬
‪‪−21,41 K‬‬
‪‪−125,10 K‬‬
‪‪−48,80 K‬‬
‪‪−42,17 K‬‬
‪‪−237,49 K‬‬
Utile operativoCrescita YoY
‪‪−127,26 K‬‬
+75,76%
‪‪−185,40 K‬‬
+61,25%
‪‪−84,43 K‬‬
+73,56%
‪‪−138,87 K‬‬
+50,57%
‪‪−47,73 K‬‬
+62,49%
‪‪−106,60 K‬‬
+42,50%
‪‪−79,65 K‬‬
+5,66%
‪‪−66,76 K‬‬
+51,92%
‪‪−300,75 K‬‬
‪‪16,70 K‬‬
‪‪−957,21 K‬‬
‪‪6,34 K‬‬
‪‪27,22 K‬‬
‪‪7,20 K‬‬
‪‪−2,98 K‬‬
‪‪7,38 K‬‬
‪‪8,35 K‬‬
‪‪19,95 K‬‬
Utile lordoCrescita YoY
‪‪−110,56 K‬‬
+79,43%
‪‪−1,14 M‬‬
−108,54%
‪‪−78,09 K‬‬
+77,04%
‪‪−111,64 K‬‬
+60,83%
‪‪−40,54 K‬‬
+63,34%
‪‪−109,58 K‬‬
+90,41%
‪‪−72,27 K‬‬
+7,44%
‪‪−58,41 K‬‬
+47,68%
‪‪−280,80 K‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−110,56 K‬‬
‪‪−1,14 M‬‬
‪‪−78,09 K‬‬
‪‪−111,64 K‬‬
‪‪−40,54 K‬‬
‪‪−109,58 K‬‬
‪‪−72,27 K‬‬
‪‪−58,41 K‬‬
‪‪−280,80 K‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Utile nettoCrescita YoY
‪‪−110,56 K‬‬
+79,43%
‪‪−1,14 M‬‬
−108,54%
‪‪−78,09 K‬‬
+77,04%
‪‪−111,64 K‬‬
+40,71%
‪‪−40,54 K‬‬
+63,34%
‪‪−109,58 K‬‬
+90,41%
‪‪−72,27 K‬‬
+7,44%
‪‪−58,41 K‬‬
+47,68%
‪‪−280,80 K‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−110,56 K‬‬
‪‪−1,14 M‬‬
‪‪−78,09 K‬‬
‪‪−111,64 K‬‬
‪‪−40,54 K‬‬
‪‪−109,58 K‬‬
‪‪−72,27 K‬‬
‪‪−58,41 K‬‬
‪‪−280,80 K‬‬
‪−0,03‬
+79,43%
‪−0,28‬
−108,55%
‪−0,02‬
+77,03%
‪−0,03‬
+44,54%
‪−0,01‬
+67,29%
‪−0,02‬
+91,04%
‪−0,02‬
+10,53%
‪−0,01‬
+50,39%
‪−0,06‬
‪−0,03‬
+79,43%
‪−0,28‬
−108,55%
‪−0,02‬
+77,03%
‪−0,03‬
+44,54%
‪−0,01‬
+67,29%
‪−0,02‬
+91,04%
‪−0,02‬
+10,53%
‪−0,01‬
+50,39%
‪−0,06‬
‪‪4,11 M‬‬
‪‪4,11 M‬‬
‪‪4,11 M‬‬
‪‪4,40 M‬‬
‪‪4,62 M‬‬
‪‪4,40 M‬‬
‪‪4,26 M‬‬
‪‪4,62 M‬‬
‪‪4,11 M‬‬
‪‪4,11 M‬‬
‪‪4,11 M‬‬
‪‪4,40 M‬‬
‪‪4,62 M‬‬
‪‪4,40 M‬‬
‪‪4,26 M‬‬
‪‪4,62 M‬‬
EBITDACrescita YoY
‪‪−99,28 K‬‬
+79,78%
‪‪−203,64 K‬‬
+54,82%
‪‪−66,45 K‬‬
+77,17%
‪‪−138,07 K‬‬
+45,40%
‪‪−46,93 K‬‬
+52,73%
‪‪−105,80 K‬‬
+48,05%
‪‪−79,65 K‬‬
−19,86%
‪‪−66,76 K‬‬
+51,65%
‪‪−299,16 K‬‬
EBITCrescita YoY
‪‪−127,26 K‬‬
+75,76%
‪‪−185,40 K‬‬
+61,25%
‪‪−84,43 K‬‬
+73,56%
‪‪−138,87 K‬‬
+50,57%
‪‪−47,73 K‬‬
+62,49%
‪‪−106,60 K‬‬
+42,50%
‪‪−79,65 K‬‬
+5,66%
‪‪−66,76 K‬‬
+51,93%
‪‪−300,75 K‬‬
‪‪−137,07 K‬‬
‪‪−196,46 K‬‬
‪‪−130,53 K‬‬
‪‪−152,14 K‬‬
‪‪−81,58 K‬‬
‪‪−111,90 K‬‬
‪‪−94,23 K‬‬
‪‪−71,37 K‬‬
‪‪−359,08 K‬‬